Evidence map›Paper›PMID 26099313›Full record

ArticleHuman genetics2015

Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome.

Martine Tetreault, Somayyeh Fahiminiya, Hana Antonicka, Grant A Mitchell, Michael T Geraghty, Matthew Lines, Kym M Boycott, Eric A Shoubridge, John J Mitchell, Care4Rare Canada Consortium and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Martine TetreaultDepartment of Human Genetics, McGill University, Montreal, QC, H3A 1B1, Canada, Martine.tetreault@mcgill.ca.
Somayyeh Fahiminiya
Hana Antonicka
Grant A Mitchell
Michael T Geraghty
Matthew Lines
Kym M Boycott
Eric A Shoubridge
John J Mitchell
Care4Rare Canada Consortium
Jacques L Michaud
Jacek Majewski
McGill University · CAUniversité de Montréal · CAUniversity of Ottawa · CAChildren's Hospital of Eastern Ontario · CAMcGill University and Génome Québec Innovation Centre · CAMontreal Children's Hospital · CAMontreal Neurological Institute and Hospital · CA

Funding

Canadian Institutes of Health Research MT_15460
6 · The paper itself

Abstract

Leigh syndrome (LS) is a rare heterogeneous progressive neurodegenerative disorder usually presenting in infancy or early childhood. Clinical presentation is variable and includes psychomotor delay or regression, acute neurological or acidotic episodes, hypotonia, ataxia, spasticity, movement disorders, and corresponding anomalies of the basal ganglia and brain stem on magnetic resonance imaging. To date, 35 genes have been associated with LS, mostly involved in mitochondrial respiratory chain function and encoded in either nuclear or mitochondrial DNA. We used whole-exome sequencing to identify disease-causing variants in four patients with basal ganglia abnormalities and clinical presentations consistent with LS. Compound heterozygote variants in ECHS1, encoding the enzyme enoyl-CoA hydratase were identified. One missense variant (p.Thr180Ala) was common to all four patients and the haplotype surrounding this variant was also shared, suggesting a common ancestor of French-Canadian origin. Rare mutations in ECHS1 as well as in HIBCH, the enzyme downstream in the valine degradation pathway, have been associated with LS or LS-like disorders. A clear clinical overlap is observed between our patients and the reported cases with ECHS1 or HIBCH deficiency. The main clinical features observed in our cohort are T2-hyperintense signal in the globus pallidus and putamen, failure to thrive, developmental delay or regression, and nystagmus. Respiratory chain studies are not strikingly abnormal in our patients: one patient had a mild reduction of complex I and III and another of complex IV. The identification of four additional patients with mutations in ECHS1 highlights the emerging importance of this pathway in LS.

Indexed as

ExomeAbnormalities, MultipleAmino Acid Metabolism, Inborn ErrorsCanadaChild, PreschoolDNA Mutational AnalysisEnoyl-CoA HydrataseFemaleHaplotypesHeterozygoteHumansInfantLeigh DiseaseMagnetic Resonance ImagingMaleMutationECHS1 protein, humanEnoyl-CoA HydrataseThiolester Hydrolases

Identifiers

PMID26099313
OpenAlexW2461195282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.